JLE

Epileptic Disorders

MENU

Safety profile of phenobarbital: can meta-analyses tell us the truth? Volume 13, numéro 4, December 2011

Auteur
Department of Functional Neurology and Epileptology and Institute for Children and Adolescent with Epilepsy (IDEE), Hospices Civils de Lyon, Lyon, France; Inserm U1028; CNRS UMR5292; Lyon Neuroscience Research Center, Translational and Integrative Group in Epilepsy Research, Lyon, F-69000, France

epd.2011.0467 Auteur(s) : Sylvain Rheims sylvain.rheims@chu-lyon.fr Department of Functional Neurology and Epileptology and Institute for Children and Adolescent with Epilepsy (IDEE), Hospices Civils de Lyon, Lyon, France; Inserm U1028; CNRS UMR5292; Lyon Neuroscience Research Center, Translational and Integrative Group in Epilepsy Research, Lyon, F-69000, France Correspondence: S. Rheims Phenobarbital (PB) is the oldest antiepileptic drug (AED) currently licensed for the treatment of seizure disorders [...]